MS Trust Recent Story List

Multiple sclerosis sufferer attempted to scale Ben Nevis

Wed, 1 Sep 2010 00:00:00 +0100

A woman with multiple sclerosis who attempted to reach the peak of Ben Nevis in a wheelchair has vowed to take on the mountain again - after being thwarted by a dead battery.

Most neurologists plan to prescribe oral multiple sclerosis drugs, but will proceed with caution

Wed, 1 Sep 2010 00:00:00 +0100

Study indicates that neurologists' apprehension regarding side effects won't stop them from prescribing new oral MS drugs, but concerns will likely relegate their use to second- or third-line therapy

Health experts warn of "stem cell tourism" dangers

Wed, 1 Sep 2010 00:00:00 +0100

Thousands of people are putting their health and life savings at risk to travel to private clinics around the world for unproven and potentially dangerous stem cell treatments, British experts said on Tuesday.

Stem cell firms defend record after criticism

Wed, 1 Sep 2010 00:00:00 +0100

Cell therapy companies in China and Germany who were criticized by British experts warning of the dangers of "stem cell tourism" defended themselves on Wednesday, saying their safety records were good.

JK Rowling gives £10m for Edinburgh MS centre

Tue, 31 Aug 2010 00:00:00 +0100

Author JK Rowling has donated £10m to the University of Edinburgh to set up a multiple sclerosis research clinic.

New role for pharmacists to aid patients with long-term conditions

Tue, 31 Aug 2010 00:00:00 +0100

The role of pharmacists in the treatment of patients will be increased under a new care scheme launched by [Scottish] Health Secretary Nicola Sturgeon.

Multiple sclerosis activity changes with the seasons

Tue, 31 Aug 2010 00:00:00 +0100

New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

[Canadian] Health agency dampens MS patients' hopes by rejecting clinical trials

Tue, 31 Aug 2010 00:00:00 +0100

The federal agency that funds health-care research says it is too soon to begin clinical trials on a contentious new treatment for multiple sclerosis, deflating the hopes of many patients who want to believe it will end their suffering.

Cannabis for nerve pain studied

Tue, 31 Aug 2010 00:00:00 +0100

"Smoking cannabis from a pipe can significantly reduce chronic pain in patients with damaged nerves," reported the BBC. It added that improvements in sleep and anxiety were seen.

Teriflunomide significantly reduced annualized relapse rate and was well tolerated in MS patients

Mon, 30 Aug 2010 00:00:00 +0100

First results from the TEMSO phase III trial to be presented during the ECTRIMS congress in October 2010.

Multiple sclerosis changes with the seasons

Mon, 30 Aug 2010 00:00:00 +0100

MRI-detected brain lesions more common in spring, summer, study finds.

Cannabis may relieve chronic nerve pain

Mon, 30 Aug 2010 00:00:00 +0100

Smoking cannabis from a pipe can significantly reduce chronic pain in patients with damaged nerves, a study suggests.

Study pinpoints factors that may contribute to faster progression to secondary progressive MS

Mon, 30 Aug 2010 00:00:00 +0100

In a study of over 5,000 people with MS, researchers pinpointed motor symptoms at onset (such as muscle stiffness known as spasticity) and male gender as factors associated with a faster progression from relapsing-remitting MS to secondary-progressive MS.

Multiple sclerosis program

Fri, 27 Aug 2010 00:00:00 +0100

A specialty care management program for multiple sclerosis (MS) patients may improve medication compliance and reduce both MS-related hospitalizations and MS-related medical costs, though total costs may still increase over time, according to research published in the August issue of Multiple Sclerosis.

MS trials not on horizon

Thu, 26 Aug 2010 00:00:00 +0100

Saskatoon researcher Dr Katherine Knox says she is not immediately pursuing clinical trials of the "liberation treatment" for multiple sclerosis, but the provincial health minister says the government still hopes to see studies start within the next year.

Disability benefit claimants asked for help with survey

Wed, 25 Aug 2010 00:00:00 +0100

The MS Society is calling for people claiming disability benefit to take part in a new survey.

Researcher cautions trial for MS 'liberation' therapy years away

Wed, 25 Aug 2010 00:00:00 +0100

Saskatoon researcher Dr Katherine Knox urged multiple sclerosis patients to have patience Wednesday, as a clinical trial of the so-called "liberation treatment" is years down the road, despite promised funding from the Saskatchewan government.

Northern Neurological Alliance launches website for patients with neurological conditions

Wed, 25 Aug 2010 00:00:00 +0100

The North East Neurological Partnership has launched a new website to support people living with neurological conditions.

Vitamin D found to influence over 200 genes, highlighting links to disease

Tue, 24 Aug 2010 00:00:00 +0100

The extent to which vitamin D deficiency may increase susceptibility to a wide range of diseases is dramatically highlighted in research published today.

Preliminary data in support of investigational anti-JCV antibody assay published

Tue, 24 Aug 2010 00:00:00 +0100

Clinical studies underway to further evaluate assay's potential to stratify risk in Tysabri-treated patients

Genetic effects of vitamin D studied

Tue, 24 Aug 2010 00:00:00 +0100

"Stocking up on vitamin D supplements and enjoying the summer sun could cut the risk of a host of diseases," reported the Daily Mail.

MS and arthritis may be linked to lack of sun, say scientists

Mon, 23 Aug 2010 00:00:00 +0100

Vitamin D found to exert an influence over genes associated with certain diseases more common in the northern hemisphere.

New research may impact treatment of MS

Fri, 20 Aug 2010 00:00:00 +0100

The removal of PTP-PEST can prevent overactive immune responses and could eventually help treat autoimmune diseases.

No respite

Thu, 19 Aug 2010 00:00:00 +0100

At one fell swoop, the Multiple Sclerosis (MS) Society is set to close four superb centres that give more than 1,300 people a year an enjoyable break and their carers a little time off.

Care Quality Commission publishes NHS guide

Thu, 19 Aug 2010 00:00:00 +0100

The Care Quality Commission (CQC) has published a leaflet which informs patients, their carers and families, what they can expect from the new essential standards of quality and safety.

Multiple sclerosis charity wins access road appeal

Wed, 18 Aug 2010 00:00:00 +0100

A charity building a multiple sclerosis therapy centre in Bradley Stoke has won its appeal to build an access route to the site.

Five more cases of brain infection in Tysabri patients

Wed, 18 Aug 2010 00:00:00 +0100

Biogen Idec Inc disclosed five more cases of a rare brain infection in multiple sclerosis patients on Tysabri, which it sells with Elan Corp bringing the total number of cases to 63 as of Aug 4.

NHS told to plan for new drugs

Tue, 17 Aug 2010 00:00:00 +0100

The National Prescribing Centre (NPC) has issued an early warning to NHS organisations about new medicines for which, it says, policy decisions concerning provision should be made ahead of the publication of guidance from the National Institute for Health and Clinical Excellence (NICE).

Call for 'sunshine vitamin' in milk to help beat cancer

Mon, 16 Aug 2010 00:00:00 +0100

Milk could be fortified with vitamin D to strengthen bones and prevent heart disease and cancer.

Team carry Cardiff man up Snowdon in his wheelchair

Mon, 16 Aug 2010 00:00:00 +0100

A former hill walker with multiple sclerosis has been carried in his wheelchair up and down Snowdon, Wales' highest mountain

Leeds hospital beds face axe

Fri, 13 Aug 2010 00:00:00 +0100

Inpatient beds could be reduced by a third and more treatments offered in people's homes as part of an overhaul of community neurology services at a Leeds hospital.

Social media drives MS controversy

Wed, 11 Aug 2010 00:00:00 +0100

A controversial treatment that promises relief from the daily torment of multiple sclerosis has created a deep rift between its proponents and those who say it doesn't work.

MS treatment wait for Scarborough couple

Tue, 10 Aug 2010 00:00:00 +0100

A North Yorkshire couple are facing an anxious wait to discover whether life-saving treatment for multiple sclerosis will be made available on the NHS.

Consultation on guidance about definition of disability in Equality Act 2010

Mon, 9 Aug 2010 00:00:00 +0100

The Equality Act 2010 is a new piece of legislation that will replace the Disability Discrimination Act (DDA).

Science may prove angioplasty technique helpful in treating MS

Mon, 9 Aug 2010 00:00:00 +0100

Multiple sclerosis occupies a particularly terrifying niche among chronic, disabling diseases [writes Dr David Katz].

Levels and efficacy of a marijuana-like substance in the brain controlled by newly discovered mechanism

Mon, 9 Aug 2010 00:00:00 +0100

A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.

FDA advisory committee unanimously recommends approval of investigational treatment FTY720 to treat relapsing remitting MS

Sat, 7 Aug 2010 00:00:00 +0100

An advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease.

Multiple sclerosis risk and severity linked to OAS1 genotype

Fri, 6 Aug 2010 00:00:00 +0100

Patients with multiple sclerosis (MS) are more likely to carry the AA variant of the oligoadenylate synthetase 1 (OAS1) gene than people without this disease, and having the GG genotype is associated with fewer relapses and less disease activity among MS patients undergoing beta interferon therapy.

The effect of microvascular decompression in patients with multiple sclerosis and trigeminal neuralgia

Thu, 5 Aug 2010 00:00:00 +0100

Trigeminal neuralgia (TN) in patients with multiple sclerosis (MS) is thought to be caused by demyelinating plaques within the nerve root entry zone, the trigeminal nucleus, or the trigeminal tracts.

Prescription for the right health cover

Thu, 5 Aug 2010 00:00:00 +0100

As the National Health Service braces itself for cuts, we look at the cost - and the advantages - of private medical insurance.

Patients denied cannabis spray

Thu, 5 Aug 2010 00:00:00 +0100

A cannabis-based drug that may relieve symptoms of multiple sclerosis will be denied to Calderdale patients.

Critical studies will not dissuade province from funding [CCSVI] research

Thu, 5 Aug 2010 00:00:00 +0100

Premier Brad Wall says he stands by his [Saskatchewan] government's stated willingness to fund clinical trials of a controversial new therapy for people with multiple sclerosis, even as two recent studies from Europe raise doubts about the theory behind the so-called "liberation" procedure.

The direct approach: the ultimate in personal health budgets

Thu, 5 Aug 2010 00:00:00 +0100

Graduate financial management trainee Lucy Jones, on secondment to the Department of Health, explains why she is convinced giving patients budgets is the best way to put them in control of the services they receive.

Funding cut for Leamington Spa MS respite centre

Wed, 4 Aug 2010 00:00:00 +0100

Trustees and users of a Warwickshire respite care centre for people with multiple sclerosis (MS) are reeling at news it will close next year unless a buyer is found.

Vascular MS theory takes another hit

Tue, 3 Aug 2010 00:00:00 +0100

The controversial theory that multiple sclerosis is caused by obstructed craniocervical veins - and that angioplasty might help - once again failed to stand up to another case-control study.

How Jeff's pub pals made his wheels a reality

Tue, 3 Aug 2010 00:00:00 +0100

A multiple sclerosis sufferer has been handed a new specialist wheelchair after more than a year of fundraising and support from a whole community.

The wheels come off Sally's Ben Nevis bid

Tue, 3 Aug 2010 00:00:00 +0100

An Edinburgh woman's bid to become the first wheelchair user to climb Britain's highest mountain unaided has had a rocky set-back.

New book from Judy Graham - Managing Multiple Sclerosis Naturally

Tue, 3 Aug 2010 00:00:00 +0100

Judy Graham has written a completely updated book on multiple sclerosis called Managing Multiple Sclerosis Naturally. The line she takes is that - with lifestyle changes - MS can be controlled.

New studies question vascular multiple sclerosis hypothesis and treatment

Mon, 2 Aug 2010 00:00:00 +0100

Conclude blood flow insufficiency not found to contribute to MS development.

Multiple sclerosis: antihypertensive drug ameliorates inflammation in the brain

Fri, 30 Jul 2010 00:00:00 +0100

Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis (MS) in check.

Store giant HMV under fire over disabled access

Fri, 30 Jul 2010 00:00:00 +0100

A music-lover is taking on entertainment giant HMV because he says it is discriminating against disabled people. Martin Long, who has multiple sclerosis, says the firm's store in Commercial Road, Portsmouth, is letting disabled people down by putting DVDs and CDs on the second floor.

Scientists use noses to help disabled write, surf, move

Thu, 29 Jul 2010 00:00:00 +0100

Severely disabled people may soon be able to use their noses to write, drive a wheelchair or surf the Internet, thanks to a device developed and tested by doctors in Israel.

New benefits system forces three-quarters of claimants back to work

Wed, 28 Jul 2010 00:00:00 +0100

A controversial new system for assessing whether the sick and disabled are capable of working has seen more than three-quarters of benefit claimants either told to get a job or abandoning their claim.

The Duchess of Cornwall joins the Red Wheelies as honourary member

Wed, 28 Jul 2010 00:00:00 +0100

Next time the Red Wheelies mobility scooter display team line up for a performance, it might be worth checking their faces carefully.

MS patient's plea for treatment

Wed, 28 Jul 2010 00:00:00 +0100

Ilfracombe MS sufferer Jayne Morrow and husband Dave are hoping a pioneering new treatment will help ease her condition.

Dealing with revolts by members, incorporation and payment of trustees

Tue, 27 Jul 2010 00:00:00 +0100

Tony Kennan, chair of the MS Society, tells Andy Ricketts you have to meet the challenges head-on.

Anti-closure protesters set to target York Multiple Scleroris Society's AGM

Tue, 27 Jul 2010 00:00:00 +0100

Protests against the threat of closure for a York respite care centre are set to be made at the Multiple Sclerosis Society's annual general meeting.

Labour urges debate into future of MS respite home

Tue, 27 Jul 2010 00:00:00 +0100

Labour is pressing for a debate in the Scottish Parliament on the future of Leuchie House, the respite home for multiple sclerosis sufferers in East Lothian.

Church supports stem cell project

Mon, 26 Jul 2010 00:00:00 +0100

Research being carried out in Bristol into the medical use of adult stem cells to help multiple sclerosis sufferers is being funded by the Catholic Church.

University conference to study brain cells

Thu, 22 Jul 2010 00:00:00 +0100

Neuro-scientists from around the world are gathering at the University of Portsmouth this week.

Scottish vitamin D summit captures international attention

Wed, 21 Jul 2010 00:00:00 +0100

Shine on Scotland campaigners and the MS Society Scotland held productive talks with the Scottish Government yesterday as planning continues for the Scottish Summit on Vitamin D and MS which will take place in Glasgow in September.

First step to sustainable care and support system

Tue, 20 Jul 2010 00:00:00 +0100

The first step towards creating a sustainable care and support system for all adults, that puts individuals and their families at its heart, was unveiled today by Health Secretary Andrew Lansley.

O2 Health launches Wii fit-style trials

Tue, 20 Jul 2010 00:00:00 +0100

NHS East Berkshire is to trial technology to allow patients to carry out rehabilitation exercises at home without needing to see a physiotherapist, as part of the launch of O2 Health.

NHS to collect raft of data on quality of care: Department of Health

Tue, 20 Jul 2010 00:00:00 +0100

The NHS is to be ordered to collect a raft of new measures on the quality of patient care just as the new Coalition government abolishes targets, it has been announced.

Specialists explore options for treating natalizumab-associated PML

Tue, 20 Jul 2010 00:00:00 +0100

A new case report suggests that natalizumab-associated progressive multifocal leukoencephalopathy (PML) may be successfully treated in a patient with multiple sclerosis, if caught early.

New online service to improve the information given to patients

Tue, 20 Jul 2010 00:00:00 +0100

A new on-line Information Prescriptions Service is now available to help ensure that patients get the information they need, when they need it most.

Liberating the NHS: Improving outcomes for patients

Mon, 19 Jul 2010 00:00:00 +0100

Detailed proposals for how the NHS will improve healthcare outcomes for patients and judge its success were set out in a public consultation by the Department of Health today.

Blow for MS sufferers as plan for centre fails

Mon, 19 Jul 2010 00:00:00 +0100

Plans for a multiple sclerosis centre in Bradley Stoke [Bristol] have stalled after planners turned down an application for access to the site.

Of bugs and brains: Researchers discover that gut bacteria affect multiple sclerosis

Mon, 19 Jul 2010 00:00:00 +0100

Biologists at the California Institute of Technology have demonstrated a connection between multiple sclerosis (MS) - an autoimmune disorder that affects the brain and spinal cord - and gut bacteria.

New guide to UN convention on the rights of persons with disabilities

Mon, 19 Jul 2010 00:00:00 +0100

Commission seeks assurance from Government that the treaty will be fully implemented.

NHS 'should focus on outcome goals'

Mon, 19 Jul 2010 00:00:00 +0100

The Government has set out how NHS standards are likely to be measured in future, with a focus on how well treatments and care are working for patients.

British researchers create world's first robotic legs

Fri, 16 Jul 2010 00:00:00 +0100

Two Britons living in New Zealand have built a pair of bionic legs that allow paraplegics to walk again.

Three more PML brain infections, one more death in Tysabri users

Thu, 15 Jul 2010 00:00:00 +0100

Biogen Idec Inc. disclosed three more cases of a rare brain infection in multiple sclerosis patients on Tysabri, which it sells with Elan Corp., bringing the total number of cases to 58 as of July 2.

Thousands back Leuchie

Thu, 15 Jul 2010 00:00:00 +0100

The bid to save Leuchie House is gathering momentum as close to 3,000 people have pledged their support to keep the MS facility open.

Millions of books get digitized for the disabled

Wed, 14 Jul 2010 00:00:00 +0100

For those who are blind, dyslexic or have diseases like multiple sclerosis and have difficulty turning book pages, reading the latest best seller just got easier.

Cannabinoids for the management of neuropathic pain: review of clinical effectiveness

Wed, 14 Jul 2010 00:00:00 +0100

The Canadian Agency for Drugs and Technologies in Health (CADTH) has published a review of clinical and cost effectiveness on the use of cannabinoids for the management of neuropathic pain.

Health white paper: the details

Tue, 13 Jul 2010 00:00:00 +0100

A radical new vision for the health service has been laid out by ministers effecting all areas of the NHS and healthcare.

Another day, another accent for NZ woman

Tue, 13 Jul 2010 00:00:00 +0100

An Invercargill woman believes she has foreign accent syndrome - a rare disorder which has changed her New Zealand accent to a British one.

Clinical trials of parasitic worms to treat MS, related to the "hygiene hypothesis"

Tue, 13 Jul 2010 00:00:00 +0100

At least two small clinical trials are currently underway - one supported with funding from the National MS Society - to test the idea that infection with intestinal parasites may reduce immune attacks in MS.

NHS to adopt zero tolerance approach to pressure ulcers

Tue, 13 Jul 2010 00:00:00 +0100

Pressure ulcers can cause serious pain and severe harm to patients and cost the NHS billions of pounds each year to treat. Yet in the majority of cases they can be prevented if simple measures were followed.

Health white paper - what nurses need to know

Tue, 13 Jul 2010 00:00:00 +0100

Health secretary Andrew Lansley has set out his blueprint for the future of the NHS in a white paper.

Can a controversial new treatment for multiple sclerosis offer relief?

Mon, 12 Jul 2010 00:00:00 +0100

A new treatment is giving hope to MS sufferers such as Mark Walker. So why can't he get it in Britain? Liz Hunt reports.

NHS shake-up grants new powers to doctors and patients

Mon, 12 Jul 2010 00:00:00 +0100

Patients and family doctors are to be given a central role in the NHS as the Government unveiled plans for the biggest NHS shake-up in decades.

Equity and excellence: Liberating the NHS

Mon, 12 Jul 2010 00:00:00 +0100

Secretary of State for Health Andrew Lansley today set out the Government's ambitious plans to reform the NHS during this Parliament and for the long-term.

Sleep disorders common in multiple sclerosis

Fri, 9 Jul 2010 00:00:00 +0100

Sleep disorders are highly prevalent in patients with multiple sclerosis (MS) and may exacerbate fatigue associated with the condition, according to a study presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.

USF receives patent for technology to improve treatment for neurodegenerative diseases

Thu, 8 Jul 2010 00:00:00 +0100

Umbilical cord blood cells and mannitol pass the blood-brain barrier.

MS patient takes up drag racing after drug changes life

Wed, 7 Jul 2010 00:00:00 +0100

A multiple sclerosis sufferer told today how her life was turned around after a London hospital gave her a "miracle" drug.

New website about work and disability

Wed, 7 Jul 2010 00:00:00 +0100

The UK MS Society has worked with other organisations to create Worklife, a website for people with long-term health conditions who want to stay in work, for their employers and for health professionals.

Natalizumab improves language processing in patients with multiple sclerosis

Wed, 7 Jul 2010 00:00:00 +0100

Treatment with natalizumab (Tysabri) leads to improved language processing and retrieval of newly learned verbal material in patients with multiple sclerosis (MS), according to research presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.

Interim results of ofatumumab phase II study in multiple sclerosis

Tue, 6 Jul 2010 00:00:00 +0100

Genmab announces interim results from a Phase II study of ofatumumab in RRMS.

UB neurosurgeons experimenting with MS procedures

Tue, 6 Jul 2010 00:00:00 +0100

Researchers at the University at Buffalo Neurosurgery Department began testing a new procedure last week for treating multiple sclerosis.

Movement therapies may reduce chronic pain

Mon, 5 Jul 2010 00:00:00 +0100

Yoga, tai chi, qigong and other exercises appear to help people suffering from cancer, arthritis, fybromyalgia, multiple sclerosis and other problems.

Don't ask Dr Google: How the worryingly poor online medical advice could affect your health

Sun, 4 Jul 2010 00:00:00 +0100

Soaring numbers of patients who consult 'Dr Google' about their injuries may be getting diagnoses which are wrong or incomplete, a new report revealed today.

New disability benefits system 'needs radical change or 2.5m incapacity claimants will remain unemployed'

Sat, 3 Jul 2010 00:00:00 +0100

The architect of a new benefits system has warned radical changes must be made to avert serious problems for vulnerable people.

Pregnant women 'must take vitamin D supplements'

Sat, 3 Jul 2010 00:00:00 +0100

Pregnant women in the UK should be told to routinely take vitamin D supplements, researchers say.

Clarification re media comment on Sativex

Fri, 2 Jul 2010 00:00:00 +0100

In response to a story in a regional UK media outlet yesterday, GW wishes to make the following clarification:

Simple eye test measures damage from multiple sclerosis

Thu, 1 Jul 2010 00:00:00 +0100

A quick, painless eye measurement shows promise as a way to diagnose multiple sclerosis in its very early stages, and to track the effectiveness of treatments, researchers from University of Texas Southwestern Medical Center have found in a multicentre study.

Cancer drug to treat arthritis, multiple sclerosis

Thu, 1 Jul 2010 00:00:00 +0100

A drug already available for treating cancer could also help in the treatment of a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus, say scientists.

MS sufferers in the south refused cannabis drug

Thu, 1 Jul 2010 00:00:00 +0100

Doctors across southern England have been told not to prescribe a new cannabis-based drug developed for people with multiple sclerosis (MS).

Brain atrophy responsible for depression in people battling multiple sclerosis

Thu, 1 Jul 2010 00:00:00 +0100

Study finds hippocampus is affected by imbalance in neuroendocrine system.

Clinical trial testing new multiple sclerosis treatment to launch in Buffalo

Tue, 29 Jun 2010 00:00:00 +0100

Researchers at the University at Buffalo, led by the Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy - dubbed "liberation treatment" - on MS symptoms and progression.

Patients free to buy their care with NHS money

Tue, 29 Jun 2010 00:00:00 +0100

Patients are set to be given money by the NHS to spend on healthcare services of their choice.

More power to the patient

Tue, 29 Jun 2010 00:00:00 +0100

Patients will be offered more choice and control over their healthcare with the launch of the first direct payment scheme, Care Services Minister Paul Burstow announced today.

Welfare crackdown begins with drive to reduce incapacity benefit claims

Mon, 28 Jun 2010 00:00:00 +0100

Coalition's plans include taking people off higher rate of benefits if tests reveal they are fit to do some work.

MS patients create own informal experiment, going in droves for unproven therapy

Mon, 28 Jun 2010 00:00:00 +0100

Scores, even hundreds of people with multiple sclerosis have in the last half-year or so undergone a procedure many hope will cure or at least improve their disease symptoms.

Sixty-two year old chemotherapy treatment shows promising results on progressive multiple sclerosis patients

Mon, 28 Jun 2010 00:00:00 +0100

Study shows ITMTX may have beneficial role in progressive forms of MS.

Margarine, processed meats and other foods can increase the risk of multiple sclerosis

Sun, 27 Jun 2010 00:00:00 +0100

Increased production of certain types of industrially produced foods - specifically of margarine, processed meat and sausage, jam and marmalade, chocolate and chocolate confectionary, sugar confectionary and beer - correlates statistically with an increased incidence of multiple sclerosis (MS).

Protesters hold Woodlands respite care centre demo

Fri, 25 Jun 2010 00:00:00 +0100

A demonstration has been held by protesters angry at the possible closure of the area's only respite centre for people with multiple sclerosis.

MS sufferer appeals for help as council ditch her stairlift pleas

Fri, 25 Jun 2010 00:00:00 +0100

A desperate mum suffering from agonising multiple sclerosis this week claimed East Ayrshire Council is refusing to carry out essential improvements at her house because social workers are convinced her condition will only get worse.

Anger at possible Helen Ley closure

Thu, 24 Jun 2010 00:00:00 +0100

Outrage has been expressed over the threat of closure to Helen Ley Care Centre in Leamington.

Psychological therapies offered across the NHS

Wed, 23 Jun 2010 00:00:00 +0100

Psychological therapies will continue to be rolled out across the NHS in the coming year Health Secretary Andrew Lansley announced today.

MS treatment in final clinical trial stage

Wed, 23 Jun 2010 00:00:00 +0100

Abbott Laboratories and its Massachusetts biotech partner have launched a final-stage clinical trial of their experimental treatment for multiple sclerosis.

MS drug's epic journey from folklore to lab

Tue, 22 Jun 2010 00:00:00 +0100

Research into ancient Chinese fungus that propagates inside insects yields potential relief for multiple sclerosis.

Overheating a multiple sclerosis threat

Tue, 22 Jun 2010 00:00:00 +0100

Summer heat can cause the recurrence of MS symptoms for people with multiple sclerosis, a US neurologist warns.

Direct coping and planning results in less multiple sclerosis flare-ups than dealing with stress on an emotional level

Tue, 22 Jun 2010 00:00:00 +0100

Multiple sclerosis patients who directly confronted the stress of the Second Lebanon War suffered fewer attacks than those who chose to cope with the situation by focusing on feelings.

Cannabis spray for MS: Controversial medicine that relieves pain gets go-ahead

Tue, 22 Jun 2010 00:00:00 +0100

The first cannabis-based medicine has been given the go-ahead for use in Britain by MS sufferers.

ENS 2010: Multiple sclerosis, migraine and dementia: new insights from neuroimaging

Tue, 22 Jun 2010 00:00:00 +0100

Innovative imaging techniques such as functional MRI or diffusion tensor imaging occupy an important place in modern neurology today.

Campaign to save MS Society respite centres

Tue, 22 Jun 2010 00:00:00 +0100

Petition calls for reversal of decision to close four care homes.

MS sufferers welcome first licensed cannabis-based drug

Tue, 22 Jun 2010 00:00:00 +0100

The first licensed medical drug containing whole cannabis plant extracts has been launched to treat symptoms of multiple sclerosis (MS).

Cannabis-based prescription drug approved to treat MS

Mon, 21 Jun 2010 00:00:00 +0100

A cannabis-based drug which can be taken by multiple sclerosis (MS) sufferers has been approved for use in the UK.

Cannabis-derived drug is launched in UK

Mon, 21 Jun 2010 00:00:00 +0100

A drug manufactured from cannabis went on sale in the UK Monday as a treatment for symptoms of multiple sclerosis.

Latest MS drug contains cannabis

Mon, 21 Jun 2010 00:00:00 +0100

The first licensed medical drug containing whole cannabis plant extracts has been launched to treat symptoms of multiple sclerosis (MS).

GW Pharmaceuticals on a high after multiple sclerosis medicine Sativex wins approval

Sun, 20 Jun 2010 00:00:00 +0100

Even if you were to track down the location and break into the computer-controlled greenhouse, the cannabis plants you would find at GW Pharmaceuticals' top-secret farm would be unlikely to give you the high you were hoping for.

MS sufferer's 'despair' at centre closure

Sat, 19 Jun 2010 00:00:00 +0100

A woman with severe multiple sclerosis said closing the Helen Ley Care Centre will be a "death sentence for many".

Minister recognises carers' contribution

Fri, 18 Jun 2010 00:00:00 +0100

Care services minister Paul Burstow has spoken of the outstanding contribution that carers make to society during a visit to a Lambeth GP practice.

Why certain diseases go into remission during pregnancy

Fri, 18 Jun 2010 00:00:00 +0100

During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission.

Britain approves GW Pharma's cannabis drug Sativex

Fri, 18 Jun 2010 00:00:00 +0100

GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in Britain for treating spasticity in patients with multiple sclerosis, in a landmark decision for the small drugmaker.

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in MS

Fri, 18 Jun 2010 00:00:00 +0100

A panel of experts met in June 2009 to review and discuss available data on neutralising antibodies to interferon-beta therapy (NAbs) and their practical consequences for the treatment of patients with multiple sclerosis (MS).

Call to Prime Minister David Cameron over Woodlands Respite Care Home closure

Fri, 18 Jun 2010 00:00:00 +0100

A direct appeal could be made to new Prime Minister David Cameron to try to save a threatened "lifeline" respite centre in York.

Biogen reports six new PML cases with Tysabri

Thu, 17 Jun 2010 00:00:00 +0100

Six more patients taking Biogen Idec Inc's multiple sclerosis drug Tysabri have developed a potentially deadly brain infection known as PML, the company said.

Stem cell therapy 'damage' seen in kidney disease case

Thu, 17 Jun 2010 00:00:00 +0100

A new complication has been seen in a patient with kidney disease who received stem cell therapy, scientists have warned.

New theory on CCSVI and MS needs further study, experts say

Thu, 17 Jun 2010 00:00:00 +0100

A controversial new theory suggests reduced blood flow in the azygous and internal jugular veins may be associated with MS, possibly by causing an iron overload in the brain and spinal cord.

Test could detect MS nine years in advance

Wed, 16 Jun 2010 00:00:00 +0100

A simple blood test that can predict multiple sclerosis up to nine years before symptoms appear is being developed by scientists.

Labour leader in bid to save Lothians MS respite centre

Wed, 16 Jun 2010 00:00:00 +0100

Scottish Labour leader Iain Gray is seeking an urgent meeting with health secretary Nicola Sturgeon in a bid to save Scotland's only respite home for people with multiple sclerosis.

Getting on with life with multiple sclerosis

Wed, 16 Jun 2010 00:00:00 +0100

Looking back now, Carol Galvin said there were pointers that something wasn't quite right back in 2005.

Anger over closure of Helen Ley Care Centre for MS patients

Wed, 16 Jun 2010 00:00:00 +0100

A care centre for Coventry and Warwickshire people with severe multiple sclerosis is to be closed.

Carers require a bit of looking after too

Tue, 15 Jun 2010 00:00:00 +0100

Caring for a relative is a job like no other. For a start most people don't recognise it as a real job in itself, it's just something you willingly do for a loved one, no matter the impact it has on your life.

Enrollment of first patient in phase II BG-12 combination trial in multiple sclerosis

Tue, 15 Jun 2010 00:00:00 +0100

EXPLORE trial to evaluate oral BG-12 as combination therapy for patients who continue to experience disease progression despite ongoing treatment

Start opening veins for MS patients, MDs say

Tue, 15 Jun 2010 00:00:00 +0100

People with multiple sclerosis should be able to have surgery on blocked neck veins as part of a clinical trial, says the Italian doctor who pioneered what has become known as the liberation therapy.

Doubts over vein blockages in people with MS

Mon, 14 Jun 2010 00:00:00 +0100

Serious doubts have been cast over whether a vein disorder, purported to cause MS and which was uncovered last year, actually exists.

Isolation takes toll on carers

Mon, 14 Jun 2010 00:00:00 +0100

Nearly three-quarters of people in the East of England looking after an ill, frail or disabled loved one do not have a life outside of caring, according to research.

Carers 'get no respite from role'

Mon, 14 Jun 2010 00:00:00 +0100

Eighty per cent of people in Northern Ireland looking after an ill, frail or disabled loved one do not have a life outside of their caring role, new research has suggested.

Study adds fuel to debate over MS and blocked veins

Mon, 14 Jun 2010 00:00:00 +0100

A study published online will add to the debate raging among the MS patient and research community. The paper, published in the Annals of Neurology, says researchers found no evidence that blockages in veins play a significant role in MS.

Active mind may protect MS patients

Mon, 14 Jun 2010 00:00:00 +0100

Intellectual enrichment helped preserve memory and learning in multiple sclerosis patients, study says.

Pre-empting multiple sclerosis

Sun, 13 Jun 2010 00:00:00 +0100

A breakthrough finding from Israel may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease multiple sclerosis.

Virus infection may trigger unusual immune cells to attack nerves in multiple sclerosis

Fri, 11 Jun 2010 00:00:00 +0100

A virus infection can incite the body to attack its own nerve tissue by activating unusual, disease-fighting cells with receptors for both viral and nerve proteins.

Are stem cell tourists being swindled?

Fri, 11 Jun 2010 00:00:00 +0100

Maybe, maybe not. According to the July edition of the publication Popular Science and its online companion site PopSci.com, desperate US patients are headed offshore for experimental stem cell therapies, referred to as stem cell tourism.

Zivadinov's update on chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis

Fri, 11 Jun 2010 00:00:00 +0100

Robert Zivadinov, MD, PhD provides a thoughtful update on the current status of chronic cerebrospinal venous insufficiency (CCSVI) research in multiple sclerosis.

Natalizumab an alternative for those in whom other MS treatments have failed

Fri, 11 Jun 2010 00:00:00 +0100

A new study suggests that patients with relapsing-remitting multiple sclerosis (RRMS) in whom previous treatment regimens have failed remain stable or show improvement when switched to treatment with natalizumab (Tysabri).

Over $2.4 million committed to support seven initial CCSVI grants to determine the role of CCSVI (venous insufficiency) in MS disease process

Fri, 11 Jun 2010 00:00:00 +0100

Over $2.4 million has been committed by the National MS Society (USA) and the MS Society of Canada to support seven new research projects focusing on the role of CCSVI (chronic cerebrospinal venous insufficiency) in MS.

FDA panel endorses first oral drug for multiple sclerosis [USA]

Thu, 10 Jun 2010 00:00:00 +0100

But concerns about side effects led experts to vote for post-market study of lower-dose pill.

MS Society to give up respite sites

Thu, 10 Jun 2010 00:00:00 +0100

Three respite care centres in England for people with multiple sclerosis will no longer be run by the MS Society under plans by the charity.

MS respite care centre to close

Thu, 10 Jun 2010 00:00:00 +0100

Scotland's only respite care centre for people with multiple sclerosis is to close later this year.

FDA panel: Novartis sclerosis drug safe, effective [USA]

Thu, 10 Jun 2010 00:00:00 +0100

Federal health experts [in the USA] said Thursday a first-of-a-kind multiple sclerosis drug from Novartis is safe and effective for controlling tremors, concentration problems and other symptoms of the debilitating disease.

Vitamin D exposure in childhood linked to age at onset of MS

Thu, 10 Jun 2010 00:00:00 +0100

Levels of childhood sun exposure and the presence or absence of cod liver oil supplements predict age at onset of multiple sclerosis (MS), a new study suggests.

Vitamin D linked to poor learning performance in patients with MS

Wed, 9 Jun 2010 00:00:00 +0100

A new study shows that serum vitamin D deficiency is associated with poor learning performance among patients with multiple sclerosis (MS).

Merck seeking approval for MS pill